1st Quarter - Report
FAEGRE DRINKER BIDDLE & REATH LLP for INTERNATIONAL PHARMACEUTICAL AEROSOL CONSORTIUM
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Environment/Superfund ENV
Montreal Protocol on Substances that Deplete the Ozone Layer Climate Change
Foreign entity interest: Implications for medical uses of aerosol propellants (i.e., hydrofluorocarbons and chlorofluorocarbons).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAUREEN HARDWICK | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ASTRAZENECA | United Kingdom | United Kingdom | — | $1,430 |
| GLAXOSMITHKLINE SERVICES | United Kingdom | United Kingdom | — | $1,430 |
| CHIESI FARMACEUTICI S.P.A. | Italy | Italy | — | $1,430 |
Affiliated organisations
| Organisation | Location |
|---|---|
| ABBOTT LABORATORIES | North Chicago, IL, US |
| ASTRAZENECA | Leicestershire, LE11 5R, GB |
| BOEHRINGER INGELHEIM | Washington,, DC, US |
| CHIESI FARMACEUTICI S.P.A. | I-43100 Parma, IT |
| GLAXOSMITHKLINE SERVICES UNLIMITED | Gloucestershire GL17, GB |
| INYX INC. | New York, NY, US |
| SEPRACOR INC. | Marlborough, MA, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.